Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., . . . Young, K. H. (2020). XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. BMC.
Chicago ZitierstilDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
MLA ZitierstilDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.